VCI Global to Develop Next-Generation AI Computing Data Center for the Next Industrial Revolution 11-06-2024, 19:39

LambdaTest Unveils Upgraded Underpass Desktop Application for Windows and Mac 15-11-2023, 00:08

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00